Loading
Latest filing published 16 Sept 2026 for Ange Prostatype Genomics AB. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jörgen Dahlström appears in our data through filings on Ange Prostatype Genomics AB shares, published by Finansinspektionen. The record holds 2 filings, all for trades on 15 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 September 2026: a transaction, in Ange Prostatype Genomics AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations